Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working PartyGerrit Jan Schuurhuis, Gert J. Ossenkoppele, Luca Maurillo et al.|Blood|2018Cited by 1k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Jacqueline Cloos, Sylvie Freeman et al.|Blood|2021Cited by 714
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaÉric Jourdan, Hervé Dombret, Nicolas Boissel et al.|Blood|2013Cited by 357
Circulating Immature Granulocytes With T-Cell Killing Functions Predict Sepsis Deterioration*Estelle Guérin, Bruno François, Marie Orabona et al.|Critical Care Medicine|2014Cited by 109
Multicentric Standardized Flow Cytometry Routine Assessment of Patients With Sepsis to Predict Clinical WorseningThomas Daix, François Barbier, Estelle Guérin et al.|CHEST Journal|2018Cited by 63